Immunocore Holdings (Immunocore Holdings) Additional Paid-In Capital : $1,478.9 Mil(As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Immunocore Holdings Additional Paid-In Capital?

Immunocore Holdings's quarterly additional paid-in capital increased from Sep. 2023 ($180.9 Mil) to Dec. 2023 ($1,455.2 Mil) and increased from Dec. 2023 ($1,455.2 Mil) to Mar. 2024 ($1,478.9 Mil).

Immunocore Holdings's annual additional paid-in capital increased from Dec. 2021 ($282.2 Mil) to Dec. 2022 ($1,318.9 Mil) and increased from Dec. 2022 ($1,318.9 Mil) to Dec. 2023 ($1,455.2 Mil).

Immunocore Holdings Additional Paid-In Capital Historical Data

The historical data trend for Immunocore Holdings's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunocore Holdings Additional Paid-In Capital Chart

Immunocore Holdings Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

371.23

282.23

1,318.92

1,455.24

Immunocore Holdings Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															156.24	174.19	180.95	1,455.24	1,478.87

Immunocore Holdings Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Immunocore Holdings Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Immunocore Holdings's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunocore Holdings (Immunocore Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunocore Holdings PLC (NAS:IMCR) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

6YG:Germany 6YG:Germany

Address

92 Park Drive, Milton Park, Abingdon, Oxfordshire, GBR, OX14 4RY

Website

https://www.immunocore.com

Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.